Early tumor shrinkage after first-line medical treatment of metastatic colorectal cancer: a meta-analysis

被引：0
|
作者：
Giuseppe A. Colloca
Antonella Venturino
Domenico Guarneri
机构：
[1] Ospedale Civile di Sanremo,Department of Oncology
来源：
International Journal of Clinical Oncology | 2019年 / 24卷
关键词：
Early tumor shrinkage; Chemotherapy; Endpoint; Prognosis; Bevacizumab; Cetuximab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：231 / 240
页数：9
相关论文
共 50 条
  • [1] Early tumor shrinkage after first-line medical treatment of metastatic colorectal cancer: a meta-analysis
    Colloca, Giuseppe A.
    Venturino, Antonella
    Guarneri, Domenico
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2019, 24 (03) : 231 - 240
  • [2] Capecitabine/oxaliplatin as first-line treatment for metastatic colorectal cancer: a meta-analysis
    Zhao, G.
    Gao, P.
    Yang, K. H.
    Tian, J. H.
    Ma, B.
    COLORECTAL DISEASE, 2010, 12 (07) : 615 - 623
  • [3] Network Meta-analysis of First-Line Systemic Treatment for Patients With Metastatic Colorectal Cancer
    Xu, Shan
    Sak, Ali
    Erol, Yasin Bahadir
    CANCER CONTROL, 2021, 28
  • [4] The role of biological therapy in metastatic colorectal cancer after first-line treatment: a meta-analysis of randomised trials
    E Segelov
    D Chan
    J Shapiro
    T J Price
    C S Karapetis
    N C Tebbutt
    N Pavlakis
    British Journal of Cancer, 2014, 111 : 1122 - 1131
  • [5] The role of biological therapy in metastatic colorectal cancer after first-line treatment: a meta-analysis of randomised trials
    Segelov, E.
    Chan, D.
    Shapiro, J.
    Price, T. J.
    Karapetis, C. S.
    Tebbutt, N. C.
    Pavlakis, N.
    BRITISH JOURNAL OF CANCER, 2014, 111 (06) : 1122 - 1131
  • [6] Efficacy of bevacizumab in first-line treatment of metastatic colorectal cancer: A systematic review and meta-analysis
    Baraniskin, Alexander
    Buchberger, Barbara
    Pox, Christian
    Graeven, Ulli
    Holch, Julian W.
    Schmiegel, Wolff
    Heinemann, Volker
    EUROPEAN JOURNAL OF CANCER, 2019, 106 : 37 - 44
  • [7] Early tumor shrinkage in metastatic colorectal cancer: Retrospective analysis from an irinotecan-based randomized first-line trial
    Giessen, Clemens
    Laubender, Ruediger P.
    von Weikersthal, Ludwig Fischer
    Schalhorn, Andreas
    Modest, Dominik P.
    Stintzing, Sebastian
    Haas, Michael
    Mansmann, Ulrich R.
    Heinemann, Volker
    CANCER SCIENCE, 2013, 104 (06) : 718 - 724
  • [8] Bevacizumab in combination with first-line chemotherapy in patients with metastatic colorectal cancer: a meta-analysis
    Hu, W.
    Xu, W. -S.
    Liao, X. -F.
    He, H. -J.
    MINERVA CHIRURGICA, 2015, 70 (06) : 451 - 458
  • [9] Comparison of irinotecan and oxaliplatin as the first-line therapies for metastatic colorectal cancer: a meta-analysis
    Sadayuki Kawai
    Nozomi Takeshima
    Yu Hayasaka
    Akifumi Notsu
    Mutsumi Yamazaki
    Takanori Kawabata
    Kentaro Yamazaki
    Keita Mori
    Hirofumi Yasui
    BMC Cancer, 21
  • [10] Comparison of irinotecan and oxaliplatin as the first-line therapies for metastatic colorectal cancer: a meta-analysis
    Kawai, Sadayuki
    Takeshima, Nozomi
    Hayasaka, Yu
    Notsu, Akifumi
    Yamazaki, Mutsumi
    Kawabata, Takanori
    Yamazaki, Kentaro
    Mori, Keita
    Yasui, Hirofumi
    BMC CANCER, 2021, 21 (01)
12345